Change - Announcement of Cessation::Retirement of Executive Director - Dr Wong Jun Shyan

Issuer & Securities

Issuer/ Manager
Stapled Security

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
15-Apr-2020 07:19:12
Announcement Sub Title
Retirement of Executive Director - Dr Wong Jun Shyan
Announcement Reference
Submitted By (Co./ Ind. Name)
Ngiam May Ling
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Retirement of Dr Wong Jun Shyan as an Executive Director of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and Email:

Additional Details

Name Of Person
Dr Wong Jun Shyan
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
To facilitate board renewal and Company's compliance to the Code of Corporate Governance, Dr Wong informed that he does not wish to seek re-election and will retire as an Executive Director of the Company at the close of the Company s Annual General Meeting to be held on 24 June 2020 ("AGM").

Dr Wong will remain as the Chief Executive Officer of the Company.

After having interviewed Dr Wong and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the cessation of Dr Wong as an Executive Director.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director
Chief Executive Officer
Role and responsibilities
The CEO has the executive responsibility for the day-to-day operations of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Shareholding Details
Direct Interest - 17,377,634 ordinary shares in the share capital of the Company

Deemed Interest - 15,000,000 ordinary shares in the share capital of the Company
Past (for the last 5 years)
- JL Medical (Bukit Batok) Pte Ltd
- JL Medical (Sembawang) Pte Ltd
- JL Medical (Yew Tee) Pte Ltd
- JL Medical (Woodlands) Pte Ltd
- International Specialist Eye Centre Pte Ltd
- ISEC Global Pte. Ltd.
- ISEC Eye Pte. Ltd.
- ISEC Sdn. Bhd.
- ISEC (Penang) Sdn. Bhd.
- Southern Specialist Eye Centre Sdn. Bhd.
- ISEC (Sibu) Sdn. Bhd.
- Indah Specialist Eye Centre Sdn. Bhd.
- ISEC Myanmar Co., Ltd.